Document is current
Any future updates will be listed below
-
Authors
Shi, Yuankai https://orcid.org/0000-0002-8685-6744
Wu, Jianqiu
Wang, Zhen
Zhang, Liling
Wang, Zhao
Zhang, Mingzhi
Cen, Hong
Peng, Zhigang
Li, Yufu
Fan, Lei
Guo, Ye
Ma, Liping
Cui, Jie
Gao, Yuhuan
Yang, Haiyan
Zhang, Hongyu
Wang, Lin
Zhang, Weihua
Zhang, Huilai
Xie, Liping
Jiang, Ming
Zhou, Hui
Shuang, Yuerong
Su, Hang
Ke, Xiaoyan
Jin, Chuan
Du, Xin
Du, Xin
Liu, Li
Xi, Yaming
Ge, Zheng
Feng, Ru
Zhang, Yang
Zhou, Shengyu
Xie, Fan
Wang, Qian
-
Funding
Funding for this research was provided by:
China National Major Project for New Drug Innovation (2017ZX09304015)
Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (2016-I2M-1-001)
- License Information
-
More Information
Article History
Received: 12 November 2020
Accepted: 1 January 2021
First Online: 12 January 2021
Ethics approval and consent to participate
: The study was done in accordance with the Declaration of Helsinki and ICH guidelines for Good Clinical Practice. The protocol, protocol amendments, and patient informed consent were reviewed and approved by the relevant independent ethics committee at each participating study site prior to implementation. Written informed consent was obtained from all patients prior to enrolment.
: Not applicable.
: FX and QW are employees of Genor Biopharma Co., Ltd., China. The other authors declared no competing interests.
